Spironolactone prescribed for dermatologic conditions is associated with blood pressure changes in patients taking concomitant antihypertensive medications.
Does spironolactone treatment for dermatologic conditions affect blood pressure in patients on concomitant antihypertensives?
Absolute Event Rate: 0% vs 0%
Dr. Lipner has served as a consultant for Veradermics. Dr. Chernoff has served as a consultant for Incyte. The authors declare no conflicts of interest. The data that support the findings of this study are available from the corresponding author upon reasonable request.
Chan et al. (Tue,) reported a other. Spironolactone prescribed for dermatologic conditions is associated with blood pressure changes in patients taking concomitant antihypertensive medications.